Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease

Authors:

Abstract
OBJECTIVE: N-glycosylation is a functional posttranslational modification of immunoglobulins (Igs). We hypothesized that specific IgG N-glycans are associated with incident type 2 diabetes and cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS: We performed case-cohort studies within the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam cohort (2,127 in the type 2 diabetes subcohort [741 incident cases]; 2,175 in the CVD subcohort [417 myocardial infarction and stroke cases]). Relative abundances of 24 IgG N-glycan peaks (IgG-GPs) were measured by ultraperformance liquid chromatography, and eight glycosylation traits were derived based on structural similarity. End point–associated IgG-GPs were preselected with fractional polynomials, and prospective associations were estimated in confounder-adjusted Cox models. Diabetes risk associations were validated in three independent studies. RESULTS: After adjustment for confounders and multiple testing correction, IgG-GP7, IgG-GP8, IgG-GP9, IgG-GP11, and IgG-GP19 were associated with type 2 diabetes risk. A score based on these IgG-GPs was associated with a higher diabetes risk in EPIC-Potsdam and independent validation studies (843 total cases, 3,149 total non-cases, pooled estimate per SD increase 1.50 [95% CI 1.37–1.64]). Associations of IgG-GPs with CVD risk differed between men and women. In women, IgG-GP9 was inversely associated with CVD risk (hazard ratio [HR] per SD 0.80 [95% CI 0.65–0.98]). In men, a weighted score based on IgG-GP19 and IgG-GP23 was associated with higher CVD risk (HR per SD 1.47 [95% CI 1.20–1.80]). In addition, several derived traits were associated with cardiometabolic disease incidence. CONCLUSIONS: Selected IgG N-glycans are associated with cardiometabolic risk beyond classic risk factors, including clinical biomarkers.
Funding Information
  • Lemann Foundation
  • European Union (05F02, SOC 95201408)
  • Federal Ministry of Science, Germany (EA 9401)
  • European Structural and Investment Funds: Research and Development (KK.01.2.1.01.0003)
  • German Research Foundation (WI5132/1-1)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK112940)
  • National Heart Lung and Blood Institute (HL 117861, K24 HL136852, R01 HL134811)
  • Croatian National Centre of Research Excellence (KK.01.1.1.01.0010)
  • Centre of Competence (KK.01.2.2.03.0006)
  • German Ministry of Education and Research (BMBF) and State of Brandenburg (82DZD00302, 82DZD03D03)
  • European Community (05F02, SOC 98200769)
  • German Cancer Aid (70-2488-Ha)
  • SciLifeLab & Wallenberg Data Driven Life Science Program (KAW 2020.0239)
  • Horizon 2020 (721815)
  • Horizon 2020 (722095)

This publication has 38 references indexed in Scilit: